Samrat Pharmachem Ltd

Meeting Details

• Date, time, and venue: 14 November 2026, 02:00 P.M., at Corporate Office, 701/702, Business Square, Andheri (West), Mumbai.

Key Agenda Items

• Un-Audited Financial Results under Ind-AS for quarter ended September 30, 2026.

Other Notes

• Notice of the board meeting to be available on the company's website.
• Intimation to exchanges and press/website announcements after Board Meeting.

Samrat Pharmachem Limited — Trading Window closed from October 1, 2026 till 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended September 30, 2026

AGM Details

• AGM held on 23 Sep 2026 at 1:00 PM IST via VC/OAVM.
• Remote e-voting window: 20–22 Sep 2026; e-voting at AGM on 23 Sep 2026.
• Record/cut-off date for voting: 16 Sep 2026.
• Total shareholders on record date: 6150.

Key Resolutions

• Resolution 1: Adopt audited standalone financial statements for year ended 31 March 2026.
• Resolution 2: Re-appoint director by rotation (Megh Mehta).
• Resolution 3: Appoint Statutory Auditors for five-year term.
• Resolution 4: Ratify remuneration of Cost Auditors.

Voting Results

• Resolution 1: Passed by ordinary majority; in-favor 1,398,773; against 35,000.
• Resolution 2: Passed by ordinary majority; in-favor 1,398,773; against 35,000.
• Resolution 3: Passed by ordinary majority; in-favor 1,398,773; against 35,000.
• Resolution 4: Passed by ordinary majority; in-favor 1,398,773; against 35,000.
• All resolutions approved by simple majority.

Directors & Auditors

• Director Megh Mehta re-appointed by rotation.
• Statutory Auditors appointed for five-year term starting FY 2026-27.
• Cost Auditors remuneration ratified.

AGM Details

• 34th AGM held via VC/OAVM on Instameet; Sep 23, 2026, 01:00–01:45 IST.
• Remote e-voting conducted Sep 20–22, 2026; results to be announced within 2 working days.

Attendance & Proceedings

• 39 members attended via VC; no proxies.
• Rajesh Mehta presided as AGM Chairman.
• Aqueel Mulla appointed Scrutinizer for e-voting.

Key Resolutions

• Adopt Audited Standalone Financial Statements for FY26.
• Re-appoint Megh Mehta as Director, retiring by rotation.
• Appoint Statutory Auditor (Ordinary Resolution).
• Ratify Cost Auditors' remuneration (Ordinary).

Voting Status

• Combined voting results to be announced within 2 working days.

Directors & Governance

• Megh Mehta to be re-appointed as Director.

Auditor Observations

• Statutory Auditor's report unqualified; Secretarial Auditor's report qualified.

AGM Details

• 34th AGM on September 23, 2026 at 1:00 PM IST via VC/OAVM.

Book Closure

• Register of Members and share transfer books closed Sept 20–22, 2026.

Remote E-Voting

• Remote e-voting from Sept 20, 2026, 9:00 AM to Sept 22, 2026, 5:00 PM IST.

Record Date

• Record date for voting rights is Sept 16, 2026.

Document Access

• Annual Report and AGM Notice emailed to members Aug 27, 2026.

Financial snapshot

• Revenue from operations ₹28,972.12 lakh; total ₹29,055.49 lakh (FY2025-26).
• EBITDA negative ₹130.59 lakh; PAT negative ₹331.20 lakh.
• EPS basic: ₹-10.72; export turnover ₹690 lakh (FOB).
• Capex ₹628.68 lakh; YoY turnover growth about 1%.
• Net assets: total assets ₹12,441.57 lakh; equity ₹6,817.92 lakh.

Dividends & capital allocation

• Dividend for FY2025-26 not declared due to operational losses.
• Dividend paid in prior year ₹30.90 lakh.

Capital structure & liquidity

• Share capital ₹308.97 lakh; unchanged year-on-year.
• Short-term borrowings ₹1,070.73 lakh; no long-term borrowings.
• Current ratio 1.86; debt-equity 0.16.
• Net cash from operating activities ₹887.99 lakh.
• Total assets ₹12,441.57 lakh; total equity ₹6,817.92 lakh.

Operations & exports

• Export FOB turnover ₹690 lakh; exports grew from ₹575 lakh.
• Two plants aimed at efficiency and productivity improvements.
• Total employees 30; plants located at Ankleshwar, Gujarat.
• Shares dematerialised; ISIN INE103E01016.

Governance & controls

• Board: 7 directors; 3 executive, 4 independent; 9 board meetings held.
• Statutory auditors Shah & Savla LLP; Cost auditors S. N. Addagatla & Co.
• Notice proposes Divyesh J Shah & Associates as statutory auditors for 5-year term.
• BSE show-cause for delayed annual report; Rs 2,000 + GST fine.
• Secretarial audit by A. A. Mulla & Associates; Annexure III with qualifications addressed.

CSR & ESG

• CSR expenditure ₹23.29 lakh; activities include animal welfare, education, relief.
• CSR committee comprises seven directors; four to attend four meetings.
• CSR policy available on company website; average net profit used for CSR obligation.

Risks, controls & outlook

• Currency risk managed; 1% INR movement could impact PBT by ~₹41.46 lakh.
• The company faces cash losses; management focusing on cost control and productivity.
• Management asserts adequate internal controls; regular audits and MIS enhancements.

Unaudited Standalone Q1 FY2026 results

• Unaudited standalone Q1 FY2026 results approved: revenue 7,976.10; total income 8,074.92; PBT 158.53; PAT 87.60.

Governance actions

• Audit Committee reviewed results; Board took on record at meeting.

Business profile

• Single business segment: pharmaceutical chemicals.